biostudies-literatureUnknown11Negash R<h4>Introduction</h4>Feline Infectious Peritonitis (FIP) has historically been a fatal coronavirus disease in cats. In recent years, the therapeutic agent GS-441524, developed by Gilead Sciences, was found to be a successful treatment for FIP in most patients in clinical trials. However, this particular drug has remained stalled in the therapeutic pipeline, leaving patients and cat owners without a licensed medication. In the meantime, online social media platforms began to emerge, connecting cat owners with a community of citizen non-veterinary professionals sourcing unlicensed GS-441524.<h4>Methods</h4>This study prospectively followed participants (<i>N</i> = 141) that successfully completed 12 weeks of treatment, capturing their treatment experiences with self-administered GS-441524-liFrontiers in veterinary science1377207https://www.ebi.ac.uk/biostudies/studies/S-EPMC11233523biostudies-literatureOwner experience and veterinary involvement with unlicensed GS-441524 treatment of feline infectious peritonitis: a prospective cohort study.PMC11233523Jacque NLi ENovicoff WNegash REvans SJMfalseOwner experience and veterinary involvement with unlicensed GS-441524 treatment of feline infectious peritonitis: a prospective cohort study.<h4>Introduction</h4>Feline Infectious Peritonitis (FIP) has historically been a fatal coronavirus disease in cats. In recent years, the therapeutic agent GS-441524, developed by Gilead Sciences, was found to be a successful treatment for FIP in most patients in clinical trials. However, this particular drug has remained stalled in the therapeutic pipeline, leaving patients and cat owners without a licensed medication. In the meantime, online social media platforms began to emerge, connecting cat owners with a community of citizen non-veterinary professionals sourcing unlicensed GS-441524.<h4>Methods</h4>This study prospectively followed participants (<i>N</i> = 141) that successfully completed 12 weeks of treatment, capturing their treatment experiences with self-administered GS-441524-li2024-01-01T00:00:00Z20242025-04-19T01:07:25.466Z2025-04-07T12:05:31.957ZS-EPMC112335233898898610.3389/fvets.2024.1377207